Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2010-08-11 to 2011-03-03
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2011
Report date:
2011

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
EPA OPPTS 870.1100 (Acute Oral Toxicity)
Deviations:
no
Qualifier:
according to guideline
Guideline:
OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
Deviations:
no
GLP compliance:
yes
Test type:
acute toxic class method
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
benzyl butyl cis-cyclohexane-1,2-dicarboxylate
Cas Number:
1931129-39-3
Molecular formula:
C19H26O4
IUPAC Name:
benzyl butyl cis-cyclohexane-1,2-dicarboxylate
Test material form:
other: clear yellow liquid
Details on test material:
- Name of test material (as cited in study report): Santicizer Platinum P1400
- Supplied by Ferro Corporation
- Data received: 08/09/10
- Storage: Room temperature and humidity
- Description: Clear yellow liquid
- Specific Gravity: 1.05
- Sample preparation: Used as received
Specific details on test material used for the study:
Identity: Santicizer Platinum P-1400
Batch:: RP-620
Supplier: Ferro Corporation
Date Received: 19 August 2010
Storage: Room temperature and humidity
Description: Clear yellow liquid
Specific gravity: 1.05
Sample Preparation: Used as received

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Ace Animals, Boyertown, PA on 11/09/10
- Age at study initiation: Born on 09/14/10
- Weight at study initiation: 179-184 grams for males and 291-324 for females
- Fasting period before study: 16-20 hours prior dosing
- Housing: suspended wire cages
- Diet (e.g. ad libitum): Fresh PMI Rat Chow (Diet#5012) was freely available except for 16-20 hours prior dosing
- Water (e.g. ad libitum): freely available
- Acclimation period: 5 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): parameters deviated from protocol - not adverse effect on the study animals or the integrity of the study
- Humidity (%): parameters deviated from protocol - not adverse effect on the study animals or the integrity of the study
- Air changes (per hr): no info
- Photoperiod (hrs dark / hrs light): 12 hr light/12 hr dark

TEST DATES:
Study initiation: 08 November 2010
Experimental Start Date: 17 November 2010
Experiment Term date: 06 December 2010
Draft Report Signed: 06 January 2011
Final Report Signed: 03 March 2011

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
unchanged (no vehicle)
Details on oral exposure:
VEHICLE
- Concentration in vehicle: 2000 mg/kg
- The test article was used as received and the dose was based on the sample weight as calculated from the specific gravity.
Doses:
1 single dose: 2000 mg/kg
No. of animals per sex per dose:
3 males and 3 females
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: half hr, 1, 2, 3 hr post dose and once daily for 14 days
- Necropsy of survivors performed: yes
- Other examinations performed: mortality, toxicity and pharmacological effects
Statistics:
Not available

Results and discussion

Effect levels
Key result
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Based on:
test mat.
Mortality:
All animals survived the 2000 mg/kg oral dose
Clinical signs:
other: No abnormal physical signs were observed during the treatment
Gross pathology:
No effects
Other findings:
No additional observations

Any other information on results incl. tables

Table 1. Body Weights and Dose Volume

Animal No.

Sex

Dose Volume (mL)

Body Weight (g)

Day 0

Day 7

Day 14

1

Female

0.34

179

246

262

2

Female

0.34

180

238

265

3

Female

0.35

184

243

277

Mean

181

242

268

S.D.

2.6

4.0

7.9

#

3

3

3

 

4

Male

0.61

320

384

418

5

Male

0.62

324

399

437

6

Male

0.55

291

363

398

Mean

312

382

418

S.D.

18.0

18.1

19.5

#

3

3

3

Table 2. Necropsy Observations

Animal Number

1

2

3

4

5

6

Sex

Female

Female

Female

Male

Male

Male

Death (D) / Sacrifice (S)

S

S

S

S

S

 

Observation

 

 

Appeared normal / No findings

X

X

X

X

X

X

Applicant's summary and conclusion

Interpretation of results:
Category 5 based on GHS criteria
Conclusions:
Based on the results observed, the LD50 of the test material Santicizer Platinum P1400 was determined to be greater than 2000 mg/Kg body weight in rats.
Executive summary:

The potential for oral acute toxicity of the test material Santicizer Platinum P1400 was determined according the OECD 423 and OPPTS 870.1000 Testing Guidelines. Three males and three females Sprague Dawley were dosed orally with 2000 mg/Kg of Santicizer Platinum P1400. The single dose was based on the sample weight as calculated from the specific gravity. A single dose was administered orally by syringe and dosing needle.

The animals were observed for mortality, body weight changes, general toxicity and pharmacological effects. All animals survived until the end of the treatment. No abnormal physical signs nor changes in body weights related to the treatment were observed. The gross pathology were normal. Based on the results of this study, the LD50 was considered to be greater than 2000 mg/Kg bw.